Neosum Pharmaceuticals Private Limited

Neosum Pharmaceuticals Private Limited - trading in Delhi, India. FY 2026 financials & compliance.
CIN U51909DL2019PTC346951 Incorporated 06 March 2019 ROC Delhi HQ Delhi, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2022
₹3.37 Lakh
▲ 25% YoY
Net loss · FY 2022
₹15,558
Net margin -4.6%
EBITDA · FY 2022
-₹15,298
EBITDA margin -4.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Neosum Pharmaceuticals Private Limited

Data last updated:

Neosum Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 06 March 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2019PTC346951. Its GSTIN is 09AAGCN4396M1ZP (Uttar Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhavna Kumari and Ravi Dutt.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at H.No. 9 Gali No.1 Ekta Gali Jogri Pur Gokal Pur, Delhi, India – 110094.

As per the financials filed for FY 2022, the company reported a revenue of ₹3.37 Lakh, a growth of 25% compared to the previous year. For the same year it recorded a net loss of ₹15,558 (net margin -4.6%) and EBITDA of -₹15,298 (EBITDA margin -4.5%). Revenue has grown at a compounded annual rate (CAGR) of 264% over three years.

Company details

CIN U51909DL2019PTC346951
Registration Number 346951
Incorporation Date 06 March 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022

Contact details

Neosum Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    H.No. 9 Gali No.1 Ekta Gali Jogri Pur Gokal Pur, Delhi, India – 110094
  • Industry
    Trading, Specialty, Wholesale

To see the full contact details of Neosum Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Neosum Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Neosum Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Neosum Pharmaceuticals Private Limited, buy the company report.

Financials of Neosum Pharmaceuticals Private Limited

FY 2022 filings available

Neosum Pharmaceuticals Private Limited reported revenue of ₹3.37 Lakh (up 25% YoY) for FY 2022.

Revenue · FY 2022
₹3.37 Lakh ▲ 25%
Net loss · FY 2022
₹15,558 margin -4.6%
EBITDA · FY 2022
-₹15,298 margin -4.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 264%
EBITDA CAGR growth
1 year
▼ 260%
3 years · compounded
▼ 32%

Revenue has grown at a compounded annual rate (CAGR) of 264% over three years, including 25% growth in the latest year. EBITDA fell 260% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations₹3.37 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹15,298
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹15,558
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin-4.5%
Net Profit Margin-4.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Neosum Pharmaceuticals Private Limited, buy the company report.

Board of directors of Neosum Pharmaceuticals Private Limited

Neosum Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bhavna KumariDirector24 Jul 20233 Years 3 MonthsCurrent
Ravi DuttDirector06 Mar 20197 Years 8 MonthsCurrent

Peer comparison

Neosum Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Ambiosis Pharmaceuticals Private Limited₹3.41 Lakh (FY 2025)5.0%Bhopal, Madhya Pradesh, India
Sylum Pharmaceuticals Private Limited₹3.38 Lakh (FY 2022)85.0%Solan, Himachal Pradesh, India
Neosum Pharmaceuticals Private Limitedthis company₹3.37 Lakh (FY 2022)-₹15,558-4.6%25.0%Delhi, India
Nassid Pharmaceuticals Private Limited₹3.34 Lakh (FY 2017)-2.0%Lucknow, Uttar Pradesh, India

To see the full peer comparison of Neosum Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Neosum Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Neosum Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAGCN4396M1ZPUttar PradeshActive01 May 2019

To see the full GST registrations and return filing status of Neosum Pharmaceuticals Private Limited, buy the company report.

Recent activity

Neosum Pharmaceuticals Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Rohan Kumar ceased to be Director on 25 Jul 2023.

Ceased
Rohan Kumar ceased to be Director.
Appointed
Bhavna Kumari was appointed as Director.
AGM
Neosum Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Neosum Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi.
Appointed
Ravi Dutt was appointed as Director.
Incorporation
06 Mar 2019
Neosum Pharmaceuticals Private Limited was registered on 06 Mar 2019 with Roc Delhi & aged 7 years 8 months as per MCA records.

Frequently asked questions

Neosum Pharmaceuticals is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 06 March 2019 (7+ years old) and is registered under CIN U51909DL2019PTC346951.

Neosum Pharmaceuticals has 2 current directors:

The latest financial statements of Neosum Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Neosum Pharmaceuticals is 09AAGCN4396M1ZP, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Neosum Pharmaceuticals is U51909DL2019PTC346951. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Neosum Pharmaceuticals was incorporated on 06 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Neosum Pharmaceuticals by revenue are Ambiosis Pharmaceuticals Private Limited, Sylum Pharmaceuticals Private Limited, Nassid Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Rohan Kumar ceased to be Director on 25 Jul 2023. Bhavna Kumari was appointed as Director on 24 Jul 2023. Ravi Dutt was appointed as Director on 06 Mar 2019.

The registered office of Neosum Pharmaceuticals is at H.No. 9 Gali No.1 Ekta Gali Jogri Pur Gokal Pur, Delhi, India – 110094.

Neosum Pharmaceuticals operates in the trading industry, in the specialty segment.

Neosum Pharmaceuticals can be reached at its registered office: H.No. 9 Gali No.1 Ekta Gali Jogri Pur Gokal Pur, Delhi, India – 110094.